1. Liggéeyu liggéey ak jëfandikoo gi ci cosaan ak aada
Tóor-tóor yi am japone lonicera ñooy:
Asid chlogenic (3-8%){0}} Kàdduy antiviral bu dëgër
Luteloside (2-5%){0}} anti{1} flavonoid inflamatoire
idâde{0} immunomodulatër yu amul benn
Done yiñ bind ci taarix:
Mingyi Bielu dafa wax ni top- grade ngir "tàngale "t
Compendium bu Materia Medica dafa leeral -na
Ci atum 2003 lañu boole ci sàrti pajum réew mi
2. Kàddu yi ak Mekanism yi
2.1 Pathway Antiviral
2.2 Bioactives ak ay tegtal
|
Kër |
Mbinde |
Jubluwaay |
Effect clinique |
|
Asid chlogenic |
3-8% |
hemaglutinin ci viral |
Duraasioŋ gripu 2.3d |
|
leer |
2-5% |
NF{)} κB yoon |
Wàññi IL-6 ci 65% |
|
dggal |
1-3% |
Reseptëri TLR7/8 |
Boost IFN- defar |
3.
3.1
Microscopie: Pollen triangle bu am 3 melo
HPLC emprent baraam: 7 piik yu màndargaal
kodage barke: firndelu ITS2
3.2 Xayma yu bees
Farmacopoeia chinois: Asid chlorogenic bi gëna rëy wala mu tollu ci 1.5%, luteloloside bu gëna rëy wala mu tollu ci 0.05%
US FDA: wen wu kawe<10ppm
EU: Amul benn residu pestisid buñu gis
4. Firnde klinik
4.1 Infections respiratoire yi
gripu: 42% ci wàññi gi am ci diir bu yàgg (RCT multicant)
adjuvant COVID-19: 1.8 fan lañu ko wàññi
4.2 Aplikaasioŋu joxe leeral
ay xeet: Jëfandikoo 60%
Eczema: 35% wàññi ci index SCORAD
5. Jëfandikool Optimisation
5.1 Dosing
Fagaru: 200mg/bis
Ajaay: 500mg 8h
Pajum: 5mg/kg diisaay
5.2 Mbokk yu am solo yi
Forsythia: spectre antiviral bu dëgër
Sinc: Fexe am selil imuniteer
Vitamine D: immunomodulation bu sinergik
6. Kaaraange
kategori bu njëkk: Kàmpa A (safe)
jaxasoo ak naan: mu am doole
Allergie: Rapport alergi yu bari ci pollen yi
7. Gitu tànneef ci produit
Man-mani premium:
"Dectarblow" góob (liggéeyu wax)
Flash{0}}d ci tàngoor wu woyof
Rapport test inhibition virus
Issué yu mag:
Adulte ak L. macranthodes
Yokk asid chlorogenik bu sinetik
